GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » LigaChem Biosciences Inc (XKRX:141080) » Definitions » Other Income (Expense)

LigaChem Biosciences (XKRX:141080) Other Income (Expense) : ₩11,115 Mil (TTM As of Mar. 2024)


View and export this data going back to 2013. Start your Free Trial

What is LigaChem Biosciences Other Income (Expense)?

LigaChem Biosciences's other income expense for the LigaChem Biosciences's pretax income for the three months ended in Mar. 2024 was ₩4,802 Mil. Its other income expense for the trailing twelve months (TTM) ended in Mar. 2024 was ₩11,115 Mil.


LigaChem Biosciences Other Income (Expense) Historical Data

The historical data trend for LigaChem Biosciences's Other Income (Expense) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LigaChem Biosciences Other Income (Expense) Chart

LigaChem Biosciences Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Income (Expense)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3,168.83 19,896.41 6,351.09 -1,328.86 -204.01

LigaChem Biosciences Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Other Income (Expense) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1,253.62 158.45 139.22 6,015.23 4,801.62

LigaChem Biosciences Other Income (Expense) Calculation

Other income expense includes minority interest. Minority interest is a significant but non-controlling ownership of less than 50% of a company's voting shares by either an investor or another company.

Other Income (Expense) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩11,115 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


LigaChem Biosciences  (XKRX:141080) Other Income (Expense) Explanation

Minority interest is reported on the consolidated income statement as a share of profit belonging to minority shareholders.


LigaChem Biosciences (XKRX:141080) Business Description

Traded in Other Exchanges
N/A
Address
8-26 Munpyeongseo-ro, Daedeok-gu, Daejeon, KOR, 34302
LegoChem Biosciences Inc develops new drugs through research. The Company provides business research services, manufacturing and sale of compounds, and drug evaluation.

LigaChem Biosciences (XKRX:141080) Headlines

No Headlines